Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Markets 2017-2018 & 2019-2025 - ResearchAndMarkets.com
Akari Therapeutics Plc - American Depositary Shares (AKTX)
US:NASDAQ Investor Relations:
investor.akaritx.com/investor-relations
Company Research
Source: Business Wire
DUBLIN--(BUSINESS WIRE)--The "Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.The report predicts the global paroxysmal nocturnal hemoglobinuria (PNH) treatment market to grow with a CAGR of 11.6% over the forecast period from 2019-2025.The report on the global paroxysmal nocturnal hemoglobinuria (PNH) treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on paroxysmal nocturnal hemoglobinuria (PNH) treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.The report on paroxysmal nocturnal hemoglobinuria (PNH) treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global paroxysmal nocturnal hemogl
Show less
Read more
Impact Snapshot
Event Time:
AKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKTX alerts
High impacting Akari Therapeutics Plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AKTX
News
- Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics [Yahoo! Finance]Yahoo! Finance
- Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity [Yahoo! Finance]Yahoo! Finance
- Samir R. Patel, M.D. Appointed Interim CEO for Akari TherapeuticsGlobeNewswire
AKTX
Sec Filings
- 5/3/24 - Form 4
- 5/1/24 - Form 425
- 5/1/24 - Form 8-K
- AKTX's page on the SEC website